Thank you, David. PMT earned $31 million in net income to common shareholders in the third quarter or $0.36 per diluted common share. PMT's credit sensitive strategies contributed $26 million in pre-tax income. Of this, $17 million were from organically created CRT investments, $6 million were from non-agency subordinate MBS and $3 million were from other opportunistic investments in GSE CRT. As David mentioned, the outlook for our current investments in organically created CRT remains favorable with a low underlying current weighted average loan-to-value ratio below 50% and a 60-day delinquency rate of 1.23%, both as of September 30th. The interest rate sensitive strategies contributed pre-tax income of $500,000. The fair value of PMT's MSR investment decreased by $84 million, as the decrease in mortgage rates drove an increase in future prepayment projections. These fair value declines were offset by the combined impact of changes in the fair value of MBS, interest rate hedges and related income tax effects. MBS fair values increased by $128 million due to the decline in mortgage rates, interest rate hedges decreased by $67 million. Fair value declines on MSRs and interest rate hedges held in PMT's taxable REIT subsidiary drove the $15 million tax benefit this quarter. Inclusive of the tax benefit, the interest rate segment -- the interest rate sensitive segment contributed approximately $19 million to net income. The fair value of CMC's MSR asset at the end of the quarter was $3.8 billion, down slightly from $3.9 billion at June 30th as fair value declines in runoff from prepayments more than offset new investments from loan production. Delinquency rates for borrowers underlying PMC's MSR portfolio remain low while servicing advances outstanding decreased to $71 million from $83 million at June 30th. No principal and interest advances are currently outstanding. Income from PMT's correspondent production segment was up from last quarter, driven by higher volumes. Total correspondent loan acquisition volume was $26 billion in the third quarter, up 15% from the prior quarter, driven by the larger overall market. Conventional loans acquired for PMT's accounts totaled $5.9 billion, up 167% from the prior quarter due to PMT retaining a larger percentage of the total conventional correspondent production. We expect this percentage to decrease to approximately 15% to 25% in the fourth quarter in order to optimize PMT's capital allocation. Profitability in this segment in recent periods has benefited from the release of liabilities related to representations and warranties provided at the time of securitization as the high volumes of loans produced from 2020 to 2022 and past the three-year window for violations with minimal repurchase related losses. We expect the contribution from the release of liabilities to decline to more normalized levels over the next several quarters. The weighted average fulfillment fee rate was 19 basis points, down from 20 basis points in the prior quarter. PMT reported $35 million of net income across its strategies, excluding market-driven value changes, and the related tax impacts unchanged from the prior quarter. Looking forward, Slide 7 outlines the run rate potential expected from PMT's investment strategies over the next four quarters. PMT's current run rate reflects a quarterly average of $0.37 per share, up from $0.33 per share last quarter, primarily driven by the decline in short-term interest rates, which reduces expected financing costs. If the yield curve steepens further, we expect PMT's overall run rate would continue to increase closer to the $0.40 range, driven by overall -- higher overall yields in interest rate-sensitive strategies. Turning to capital. Liquidity is in place for repayment in full of the $210 million in exchangeable senior notes due in November. As David mentioned earlier, we strengthened our capital position, refinancing MSR and CRT term notes at more attractive rates and longer duration. At the end of the prior quarter, we issued $355 million of three and a half year MSR term notes with a cost of SOFR plus 275 basis points. In July, proceeds from that issuance were used to refinance $305 million of MSR term notes, which were at a cost of SOFR plus 419 basis points that were mature in 2027. And in August, we issued $159 million in four-year CRT term notes with the cost of SOFR plus 310 basis points, effectively refinancing $152 million of notes, which were at a cost of SOFR plus 375 basis points that were due to mature in 2025. We'll now open it up for questions. Operator?